Home  >  News
you can get e-magazine links on WhatsApp.Click here
Disease Profile + Font Resize -

Endocrine Practice of AACE Journal reveals digital therapeutics improves self-monitoring of blood glucose adherence in India

Our Bureau, Bengaluru
Thursday, May 31, 2018, 14:10 Hrs  [IST]

Clinical data published in the latest edition of Endocrine Practice, the AACE Journal established the role of Wellthy Care, a digital therapeutic platform by Wellthy Therapeutics, in improving self-monitoring of blood glucose (SMBG) for patients with type II diabetes.

The data was presented at the 27th Annual Congress of the American Association of Clinical Endocrinology (AACE) in Boston. As per clinical guidelines, a type 2 diabetic patient should check his blood glucose daily. Real World studies in India indicate that the average educated diabetes patient checks blood glucose less than once a month.

The report indicated that 104 patients recorded 1288 blood glucose readings shows how Wellthy Care can potentially help physicians personalise care for their patients by knowing the glycaemic variability. On completion of the 16 weeks program, 56% and 50% of patients reported a reduction in their fasting blood sugar and postprandial blood sugar values respectively, with significantly more readings than average at the time of the next physician appointment.

“There is an unmet need for personalised care in between doctor visits. In emerging markets like India, SMBG still remains relatively affordable versus other blood sugar measuring diagnostic tools. Real time feedback & guidance plays a crucial role for SMBG adherence and value creation, which needs tools like chat bots and self learning logic systems like those that we provide for patients. More  data leads to personalised decision support for both the doctor and the patient, which is of utmost importance to enable the respective stakeholder to action decisions leading to better outcomes, and enables patients to unlock more value from their device” said Abhishek Shah, Co-Founder and CEO, Wellthy Therapeutics.

According to Dr Rajiv Kovil, Consultant Diabetologist, SMBG is an essential tool in the optimal management of diabetes, and am glad to see clinically validated real time responses helping patients manage their blood sugar levels better.

“In-spite of the advice given by physicians to type 2 diabetes patients, compliance with SMBG in Indian patients is  low. There is a need to help, encourage and empower patients beyond the test, to enable better compliance and better glycaemic variability,” said Dr. Banshi Saboo Chairman, Dia-Care Ahmedabad, Hon. Sec of Diabetes India.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |